Amalgamated Bank’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $211K | Hold |
4,880
| – | – | ﹤0.01% | 1537 |
|
2025
Q1 | $169K | Buy |
4,880
+17
| +0.3% | +$589 | ﹤0.01% | 1570 |
|
2024
Q4 | $133K | Hold |
4,863
| – | – | ﹤0.01% | 1656 |
|
2024
Q3 | $124K | Hold |
4,863
| – | – | ﹤0.01% | 1668 |
|
2024
Q2 | $123K | Buy |
4,863
+962
| +25% | +$24.3K | ﹤0.01% | 1674 |
|
2024
Q1 | $121K | Sell |
3,901
-10,527
| -73% | -$327K | ﹤0.01% | 1691 |
|
2023
Q4 | $582K | Sell |
14,428
-1,347
| -9% | -$54.3K | ﹤0.01% | 1387 |
|
2023
Q3 | $416K | Buy |
15,775
+576
| +4% | +$15.2K | ﹤0.01% | 1501 |
|
2023
Q2 | $261K | Buy |
15,199
+1,901
| +14% | +$32.6K | ﹤0.01% | 1714 |
|
2023
Q1 | $220K | Sell |
13,298
-2,178
| -14% | -$36K | ﹤0.01% | 1763 |
|
2022
Q4 | $118K | Hold |
15,476
| – | – | ﹤0.01% | 2073 |
|
2022
Q3 | $154K | Buy |
15,476
+165
| +1% | +$1.64K | ﹤0.01% | 1949 |
|
2022
Q2 | $139K | Sell |
15,311
-483
| -3% | -$4.39K | ﹤0.01% | 2036 |
|
2022
Q1 | $160K | Sell |
15,794
-1,398
| -8% | -$14.2K | ﹤0.01% | 2025 |
|
2021
Q4 | $287K | Sell |
17,192
-285
| -2% | -$4.76K | ﹤0.01% | 1846 |
|
2021
Q3 | $819K | Sell |
17,477
-1,133
| -6% | -$53.1K | 0.01% | 1343 |
|
2021
Q2 | $1.13M | Buy |
18,610
+5,217
| +39% | +$318K | 0.01% | 1231 |
|
2021
Q1 | $825K | Buy |
13,393
+2,011
| +18% | +$124K | 0.03% | 688 |
|
2020
Q4 | $809K | Buy |
11,382
+57
| +0.5% | +$4.05K | 0.03% | 684 |
|
2020
Q3 | $425K | Sell |
11,325
-333
| -3% | -$12.5K | 0.02% | 927 |
|
2020
Q2 | $380K | Sell |
11,658
-1,381
| -11% | -$45K | 0.02% | 981 |
|
2020
Q1 | $378K | Buy |
+13,039
| New | +$378K | 0.01% | 1036 |
|